Skip to main content
Article thumbnail
Location of Repository

Mapping the role of official bioethics advice in the governance of biotechnologies in the EU: The European Group on Ethics’ Opinion on commercial cord blood banking

By A Mohr, Helen Busby, T Hervey and R Dingwall

Abstract

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/\ud by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.In the early 1990s, the EU’s proposed bioeconomic agenda provoked ethical concerns among its\ud citizenry. In response to the political impasse between economic and ethical imperatives, as well\ud as the perceived lack of democratic legitimacy, the EU established an expert bioethics advisory\ud body, known as the European Group on Ethics in Science and New Technologies (EGE). Situated\ud at the boundary between law, bioethics and economic policy, the EGE plays an ambiguous role in\ud the governance of biotechnologies in the EU. To elucidate the nature of its role and influence, this\ud paper considers the EGE as an integral element of a broader web of governance spanning EU and\ud Member State institutions. Using as a case study the emerging controversy surrounding commercial\ud cord blood banking, we explore whether the EGE and its ethical opinions on this matter have\ud contributed to the democratic legitimacy of the EU.Peer-reviewedPublisher Versio

Topics: bioethics
Publisher: Oxford University Press
Year: 2012
DOI identifier: 10.1093/scipol
OAI identifier: oai:lra.le.ac.uk:2381/10106
Journal:

Suggested articles

Citations

  1. (2003). A worldwide study of umbilical cord cell banking’. A study initiated by the EGE and funded by the Directorate General for Research,
  2. (2001). Answer to written question E-1079/01 by Ria Oomen-Ruijten given by Mr Prodi on behalf
  3. (2005). Biobanks and bioethics: the politics of legitimation’, doi
  4. (2007). Changing the field of unrelated cord blood transplantation: transplants in adults now as common as in children’, NetCord Newsletter,
  5. (1997). Commission Decision dated 16
  6. (2005). Commission Decision of 11
  7. (2005). Commission Decision of 19
  8. (2011). Communication from the Commission on the Collection and Use of Expertise by the Commission: Principles and Guidelines. ‘Improving the Knowledge Base for Better Policies’, COM(2002) 713 final.
  9. (2008). Communication on promoting the competitive environment (European Commission 1991: 1–2), where
  10. (2011). Confronting moral pluralism in posttraditional Western societies: Bioethics critically reassessed’, doi
  11. (2007). Debating the Democratic Legitimacy of the European Union. doi
  12. (2007). Democratic politics in a globalizing world: Supranationalism and legitimacy in the European Union’, doi
  13. (2004). Directive 2004/23/EC of the European Parliament and of the Council of 31 doi
  14. (1998). Directive 98/44/EC of the European Parliament and of the doi
  15. (2006). Donor Association. doi
  16. (1999). Elements of democratic legitimation in Europe: An alternative perspective’, doi
  17. (2004). Ethical aspects of umbilical cord blood banking’, doi
  18. (2005). Ethics and public policy within a digital environment’,
  19. (2012). europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2001:340E: 0167:0168:EN:PDF> accessed 22
  20. (2012). europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2002:227E: 0505:0521:EN:PDF> accessed 22
  21. (2012). europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2005:127: 0017:0019:EN:PDF> accessed 22
  22. (1995). European democracy and its critique’,West doi
  23. (2001). European Governance: A White Paper’, doi
  24. (2009). From (public?) waste to (private?) value. The regulation of private cord blood banking in Spain’,
  25. (2001). General report on the activities of the European Group on
  26. (2006). Gift not commodity? Lay people deliberating social sex selection’, doi
  27. (2009). Governing innovation’. Paper presented at Knowledge in Question: a symposium on interrogating knowledge and questioning science,
  28. (2004). Health Law and the European Union. Cambridge: doi
  29. (1989). Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling’, doi
  30. (2002). Human genetic technologies, European governance and the politics of bioethics’, doi
  31. (2006). Is the gift still good? Examining the politics and regulation of blood safety in the European Union’, doi
  32. (1991). Mandate 1991–1997, Introduction’, .europa.eu/european_group_ethics/archive/1991_1997/index_ en.htm> accessed 1
  33. (1998). Mandate 1998–2000, Introduction’, .europa.eu/european_group_ethics/archive/1998_2000/intro_ en.htm> accessed 1
  34. (2012). P6_RE(2006)0430 answers given by Mr Barroso on behalf of the Commission to Parliamentary questions by Marco Pannella on criteria and methods for the selection of the members of the
  35. (2006). P6_RE(2006)0430. Answers given by Mr Barroso on behalf of the Commission on
  36. (2001). Parliamentary written question E-1079/01 by Ria Oomen-Ruijten (PPE-DE) to the Commission,
  37. (2007). Previous Mandates/Opinions/Activities, European Group on Ethics
  38. (1991). Promoting the competitive environment for industrial activities based on biotechnology within the Community’, SEC(91) 629 final,
  39. Proposal for a Directive of the European Parliament and of the Council on setting standards of quality and safety for the donation, procurement, testing, processing, storage, and distribution of human tissues and cells’,
  40. (2003). Public bioethics and publics: consensus, boundaries, and participation in biomedical science policy’, doi
  41. Regulating human genetics: the changing politics of biotechnology governance in the European doi
  42. (2006). Royal College of Obstetricians and Gynaecologists. doi
  43. (2009). See index_en.htm> accessed 5
  44. (2006). Stem Cell Patents: European Patent Law and Ethics Report’,
  45. (2005). Swedish National Council on Medical Ethics. doi
  46. (2008). The European Group on Ethics: Law, politics and the limits of moral integration in Europe’, doi
  47. (2005). The European Union and the governance of stem cell research’,
  48. (2005). The US National Bioethics Advisory Commission as a boundary organization’, doi
  49. (2007). Umbilical Cord as Spare Parts Warehouse?
  50. (2006). Umbilical cord blood: from social gift to venture capital’, doi
  51. (2006). Why cord blood?’, doi
  52. (2002). Written question E-1843/01 by Ria Oomen-Ruijten to the Commission on 26

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.